347
Views
13
CrossRef citations to date
0
Altmetric
Review

The Gluten-Free Diet: Can Oats and Wheat Starch Be Part of It?

, MD
Pages 1-8 | Received 20 Mar 2015, Accepted 17 Aug 2015, Published online: 07 Feb 2017

REFERENCES

  • Van Berge-Henegouwen GP: Pioneer in the gluten-free diet: Willem Karel Dicke 1905–1962, over 50 years of gluten-free diet. Gut 34:1473–1475, 1993.
  • Dicke WK, Weijers HA, van de Kamer JH: Coeliac disease II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 42:34–42, 1953.
  • Wieser H: The family of storage proteins in cereals also includes secalins from rye and hordeins from barley. Baillière's Clin Gastroenterol 9:191–207, 1995.
  • Tatham AS, Marsh MN, Wieser H, Shewry PR: Conformational studies of peptides corresponding to the celiac-activating regions of α-gliadin. Biochem J 270:313–318, 1990.
  • Rocher A, Colilla F, Ortíz ML, Méndez E: Identification of three immunoreactive proteins and one α-amylase inhibitor form oat endosperm. FEBS Lett 310:37–40, 1992.
  • Hekkens WTJM: The toxicity of gliadin: a review. In McNicholl B, McCarthy CF, Fottrell PF (eds): “Perspectives in Coeliac Disease.” Lancaster, PA: MTP Press, pp. 3–14, 1978.
  • Shan L, Molberg Ø, Parrot I, Hausch F, Fíliz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science 297:2275–2270, 2002.
  • Shewry PR, Tatham AS: The prolamin storage proteins of cereal seeds: structure and evolution. Biochem J 267:1–12, 1990.
  • Platt SG, Kasarda DD: Separation and characterization of gluten fractions. Biochim Biophys Acta 243:407–415, 1971.
  • Sollid LM: Molecular basis of celiac disease. Annu Rev Immunol 18:53–81, 2000.
  • Green PHR, Jones R: “Celiac Disease. A Hidden Epidemic.” New York, NY: Harper Collins, pp. 197–206, 2006.
  • Sadiq-Butt M, Tahir-Nadeem M, Iqbal Khan MK, Shabir R, Butt MS: Oat: unique among the cereals. Eur J Nutr 47:68–79, 2008.
  • Pulído OM, Gillespie Z, Zarkadas M, Dubois S, Vavasour E, Rashid N, Switzer C, Godefroy SB: Introduction of oats in the diet of individuals with celiac disease: a systematic review. Adv Food Nutr Res 57:235–285, 2009.
  • Dissanayake AS, Truelove SC, Whitehead R: Lack of harmful effects on small-intestinal mucosa in coeliac disease. Br Med J 4:189–191, 1974.
  • Lerner A: The enigma of oats in nutritional therapy for celiac disease. Int J Celiac Dis 2:110–114, 2014.
  • Janatuinen EK, Pikkarainen PA, Kemppainen TA, Kosma VM, Järvinen RM, Uusitupa MS, Julkunen RJ: A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 333:1033–1037, 1995.
  • Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma VM, Uusitupa M, Mäki M, Julkunen RJ: Lack of cellular and humoral immunological response to oats in coeliac disease. Gut 46:327–331, 2000.
  • Janatuinen EK, Kemppainen TA, Julkunen RJK, Kosma VM, Mäki M, Heikkinen M, Uusitupa MIJ: No harm from five year ingestion of oats in coeliac disease. Gut 50:332–335, 2002.
  • Peräaho M, Kaukinen K, Mustalahti K, Vulteenaho N, Mäki M, Laippala P, Collin P: Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol 39:27–31, 2004.
  • Kaukinen K, Collin P, Huhtala H, Mäki M: Long-term consumption of oats in adult celiac disease patients. Nutrients 5:4380–4389, 2013.
  • Cooper SE, Kennedy NP, Mohamed BM, Abuzakouk M, Dunne J, Byrne G, McDonald G, Davies A, Edwards C, Kelly J, Feighery CF: Immunological indicators of celiac disease activity are not altered by long-term oats challenge. Clin Exp Immunol 171:313–318, 2013.
  • Størsrud S, Hulthén LR, Lenner RA: Beneficial effect of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences. Brit J Nutr 90:101–107, 2003.
  • Hardman CM, Garioch JJ, Leonard JN, Thomas HJW, Walker MM, Lortan JE, Lister A, Fry L: Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 337:1884–1887, 1997.
  • Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly C, Feighery C: Absence of oats toxicity in adult coeliac disease. Br Med J 313:1300–1301, 1996.
  • Picarelli A, Di Tola M, Sabbatella L, Gabrielli F, Di Cello T, Anania MC, Mastracchio A, Silano M, De Vincenzi M: Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr 74:137–140, 2001.
  • Troncone R, Maiuri L, Leone A, Mazzarella G, Maurano F, Vacca L, Ciacci C, De Vincenzi M, Auricchio S: Oat prolamines activate mucosal immune response in the in vitro cultured treated coeliac mucosa [abstract]. J Pediatr Gastroenterol Nutr 22:414, 1996.
  • Sey MS, Parfitt J, Gregor J: Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr 35:459–464, 2011.
  • Kemppainen T, Heikkinen MT, Ristikankare MK, Kosma VM, Sontag-Strohm T, Binnick O, Salovaara HO, Julkunen J: Unkilned and large amounts of oats in the coeliac disease diet: a randomized, controlled study. Scand J Gastroenterol 43:1094–1101, 2008.
  • Canadian Celiac Association: “Position Statement on Oats.” 2007.
  • Lindsay A, Moulton C: The place of oats in the coeliac diet. Arch Dis Child 34:51–55, 1959.
  • Hoffenberg EJ, Haas J, Drescher A, Barnhurst R, Osberg I, Bao F, Eisenbarth O: A trial of oats in children with newly diagnosed coeliac disease. J Pediatr 37:361–366, 2000.
  • Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky Jansson G, Ascher H, Browaldh L, Hammersjö JÅ, Lindberg E, Myrdal U, Stenhammar L: Oats to children with newly diagnosed coeliac disease: a randomized double blind study. Gut 53:649–654, 2004.
  • Koskinen O, Villanen M, Korponay-Szabó I, Lindfors K, Mäki M, Kaukinen K: Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr 48:559–565, 2009.
  • Holm K, Vuolteenaho N, Mäki M: No harm of oats in the diet of children with newly and previously diagnosed CD (Abstr). J Pediatr Gastroenterol Nutr 26:549, 1998.
  • Holm K, Mäki M, Vuolteenaho N, Mustalahti K, Ashorn M, Kaukinen K: Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 23:1463–1472, 2006.
  • CODEX Alimentarius: CODEX STAN 118-1981: Standard for foods for special dietary use for persons intolerant to gluten. Accessed at: Codexalimentarius.net.
  • Hollén E, Högberg L, Stenhammar L, Fälth-Magnusson K, Magnusson KE: Antibodies to oat prolamines (avenins) in children with celiac disease. Scand J Gastroenterol 38:742–746, 2003.
  • Hollén E, Peterson KH, Sundqvist T, Grodzinski E, Högberg L, Laurin P, Stenhammar L, Fälth-Magnusson K, Magnusson KE: Coeliac children on a gluten-free diet with or without oats display equal anti-avenin titers. Scand J Gasstroenterol 41:42–47, 2006.
  • Arentz-Hansen H, Fleckenstein B, Molberg Ø, Scott H, Koning F, Jung G, Roepstorff P, Lundin KEA, Sollid LM: The molecular basis for oat intolerance in patients with coeliac disease. PLoS Med 1:84–92, 2004.
  • Guttormsen V, Løvik A, Bye A, Bratlie J, Mørkrid L, Lundin KEA: No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease. Scand J Gastroenterol 43:161–165, 2008.
  • Segal E: Oats and coeliac disease [letter]. Br Med J 4:589, 1974.
  • Lundin KE, Nilsen EM, Scott HG, Løberg EM, Gjøen A, Bratlie J, Skar V, Méndez A, Løvik A, Kett A: Oats induced villus atrophy in coeliac disease. Gut 52:1649–1652, 2003.
  • Ellis LJ, Ciclitira PJ: Should coeliac sufferers be allowed their oats? Eur J Gastroenterol Hepatol 20:492–493, 2008.
  • Kasarda DD, Qualset CO, Mecham DK, Goodenberger DM, Strober W: A test of toxicity of bread made from wheat lacking α-gliadin coded for by the 6A chromosome. Perspect Celiac Dis 55–61, 1978.
  • Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C: Avenin fails to induce a Th1 response in coeliac tissue following in vitro cultivation. Gut 52:47–52, 2003.
  • Ribes-Koninckx C, Alfonso P, Ortigosa L, Escobar H, Suárez L, Arranz E, Méndez E: A β-turn rich oats peptide as an antigen in an ELISA method for the screening of coeliac disease in a paediatric population. Eur J Clin Invest 30:702–708, 2000.
  • Alfonso P, Soto C, Albar JP, Camafeita E, Escobar H, Suárez L, Rico M, Bruin M, Méndez E: β structure motif recognition by antigliadin antibodies in celiac disease. FEBS Lett 427:36–40, 1998.
  • Tatham A: Conformational studies of peptides corresponding to celiac activating regions of wheat α-gliadin. Biochem J 270:313–318, 1990.
  • Hardman C, Fry L, Tatham A, Thomas H, Tatham HJW: Absence of toxicity of avenin in patients with dermatitis herpetiformis [letter]. N Engl J Med 340:321, 1999.
  • Bohle M, Coats D, Karow R: “Irrigated Spring Oat Varieties.” Madras and Corvallis, OR: Central Oregon Agricultural Research Center, 1993.
  • Comino I, Real A, De Lorenzo L, Cornell H, López-Casado MA, Barro F, Lorite P, Torres MI, Cebolla A, Sousa C: 3 groups of oat cultivars react differently to moAb G12 (against main immunotoxic 33-mer) and reactivity is proportional to potential immunotoxicity of the oat cultivar. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in celiac disease. Gut 60:915–922, 2011.
  • Silano M, Di Benedetto R, Maialetti F, De Vincenzi A, Calcaterra R, Cornell HJ, De Vincenzi M: Avenins from different culivars of oats elicit response by coeliac peripheral lymphocytes. Scand J Gastroenterol 42:1302–1305, 2007.
  • Silano M, Dessi M, De Vincenzi M, Cornell H: in vitro tests indicate that certain varieties of oats may be harmful to patients with coeliac disease. J Gastroenterol Hepatol 22:528–531, 2007.
  • Real A, Comino I, De Lorenzo L, Merchan F, Gil-Humanes J, Giménez MJ, López-Casado MA, Torres MI, Cebolla A, Sousa C, Barro F, Pistón F: Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. Scand J Gastroenterol 2007; 42:1302–1305.
  • Størsrud S, Malmheden Y, Lenner RA: Gluten contamination in oat products and products naturally free from gluten. Eur Food Res Technol 217:481–485, 2003.
  • Hernando A, Mujíco J, Mena MC, Lombardia M, Méndez E: Measurements of wheat gluten and barley hordeins in contaminated oats from Europe, the United States and Canada. Eur J Gastroenterol Hepatol 20:454–554, 2008.
  • Kupper C: Dietary guidelines and implementation for celiac disease. Gastroenterology 128(Suppl):S121–S127, 2005.
  • Fric P, Gavrovska D, Nevoral J: Celiac disease, gluten-free diet and oats. Nutr Rev 69:107–115, 2011.
  • Silano M, Penas-Pozo E, Uberti F, Manferdelli S, Del Pinto T, Felli C, Budelli A, Vincentini O, Restani P: Diversity of oat varieties eliciting the early inflammatory events in celiac disease. Eur J Nutr 5:76–85, 2013.
  • Dor R, Shanahan DJ: Oats and coeliac disease [letter]. Gut 51:757–758, 2002.
  • Chartrand LJ, Russo PA, Duhaime AG, Seidman EG: Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc 97:612–618, 1997.
  • Slavin JL, Savarino V, Paredes-Díaz A, Fotopoulos G: A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res 37:1–17, 2009.
  • Waffle V: The new word on wheat starch. Gluten-Free Living 2015.
  • Kaukinen K, Collin P, Holm K, Rantala I, Vuolteenaho N, Reunala T, Mäki M: Wheat starch containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 34:163–169, 1999.
  • Peräaho M, Kaukinen K, Paasikivi K, Sievänen H, Lohiniemi S, Mäki M: Wheat starch–based gluten-free products in the treatment of newly detected coeliac disease. Prospective and randomized study. Aliment Pharmacol Ther 17:587–594, 2003.
  • Ashogbon AO: Chemical and functional properties of cocoyam starch and wheat starch blends. Int J Biotechnol Food Sci 2:54–101, 2014.
  • Lohiniemi S, Mäki M, Kaukkinen K, Laippala P, Collin P: Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch–based gluten-free diets. Scand J Gastroenterol 35:947–949, 2000.
  • Skerritt JH, Hill AS: Enzyme immunoassay for determination of gluten in foods: collaborative study. J Assoc Anal Chem 74:257–264, 1991.
  • Ciclitira PJ, Cerio R, Ellis HJ, Maxton D, Nelufer J, MacCartney JM: Evaluation of a gliadin-containing gluten-free product in coeliac patients. Hum Nutr Clin Nutr 39:303–308, 1985.
  • Ejderhamn J, Veress B, Strandvik B: The long-term effects of continual ingestion of wheat starch–containing gluten-free products in coeliac patients. In “Proceedings of the 4th International Coeliac Disease Symposium.” London, UK: St. Barts Hospital Publications, pp. 294–297, 1988.
  • Kaukinen K, Salmi T, Collin P, Huhtala H, Kärjä-Ladensuu T, Mäki M: Clinical trial: Gluten microchallenge with wheat-based starch hydrolysates in coeliac disease patients—a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 28:1240–1248, 2008.
  • Thompson T: Wheat starch, gliadin and the gluten-free diet. J Am Diet Assoc 101:1456–1459, 2001.
  • Freedman AR, Galfré G, Gal E, Ellis HJ, Ciclitira PJ: Monoclonal antibody ELISA to quantitate wheat gliadin contamination of gluten-free foods. J Immunol Methods 98:123–127, 1987.
  • Thompson T: Gluten contamination of commercial oat products in the United States [letter]. N Engl J Med 351:2021–2022, 2004.
  • Thompson T, Lee AR, Grace T: Gluten-contamination of grains, seeds and flours in the Unites States: a pilot study. J Am Diet Assoc 110:937–940, 2010.
  • Bazilee D, Martínez EA, Fuentes F: Diversity of quinoa in a biogeoraphical island: a review of constraints and potential from arid to temperate regions of Chile. Not Bot Horti Agrobot Cluj Napoca 42:289–298, 2014.
  • Zevallos VF, Ellis HJ, Suligoj T, Herencia LJ, Ciclitira PJ: Variable activation of immune response by quinoa (Chenopodium quinoa Willd.). Am J Clin Nutr 96:337–344, 2012.
  • Michali N: Amaranth seeds may help cardiovascular health and diabetes. Compr Rev Food Sci Food Saf 14:139–158, 2015.
  • Zharkov IM, Miroshnichenko LA, Zviagib AA, Bavykina IA: Amaranth flour characteristics, comparative analysis, application possibilities. Vopr Pitan 83:67–73, 2014.
  • Ortiz-Sánchez EP, Cabrera-Chavez F, de la Barca AM: Maize prolamins induce a gluten-like cellular immune response in some celiac disease patients. Nutrients 5:4174–4183, 2013.
  • Spaenij-Dekking L, Kooy-Winkelaar Y: The Ethiopain cereal Tef in celiac disease [letter]. N Engl J Med 353:1748–1749, 2005.
  • Lädeaho M-L, Mäki M, Laurila K, Huhtala H, Kaukinen K: Small bowel mucosal changes autoantibody responses after low- and moderate dose gluten challenge in celiac disease. BMC Gastroenterol 11:129, 2011.
  • Received March 20, 2015; accepted August 17, 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.